Current Signal Transduction Therapy
Volume 16, 3 Issues, 2021
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
Thematic Issue Proposal
Guest Editors who wish to submit an issue proposal to Current Signal Transduction Therapy are requested to complete the following online form. The proposal of thematic issue will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of Current Signal Transduction Therapy who will then inform Guest Editors with a decision about the submitted proposal.
Editor-in-Chief
Jingxuan Yang
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
Biography
Biography of Jingxuan Yang
Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.
Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net